Time-dependent changes in receptor/G-protein coupling in rat brain following chronic monoamine transporter blockade

Journal of Pharmacology and Experimental Therapeutics

Volumn 313, Issue 2, 2005, Pages 510-517

  O'Connor, Kerry A ^a   Porrino, Linda J ^a   Davies, Huw M L ^b   Childers, Steven R ^a  

^a WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 3BETA (2 NAPHTHYL) 2BETA PROPIONYLTROPANE; 3BETA (4 IODOPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; ALPHA 2 ADRENERGIC RECEPTOR; AMINE OXIDASE (FLAVIN CONTAINING); DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); MONOAMINE TRANSPORTER INHIBITOR; MU OPIATE RECEPTOR; NORADRENALIN; NORADRENALIN UPTAKE INHIBITOR; PROPYLNORAPOMORPHINE; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN ANTAGONIST; SPIPERONE; TROPANE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CAUDATE NUCLEUS; CONTROLLED STUDY; CORPUS STRIATUM; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG MECHANISM; DRUG RECEPTOR BINDING; HIPPOCAMPUS; LOCOMOTION; MONOAMINE METABOLISM; NONHUMAN; PRIORITY JOURNAL; PUTAMEN; RAT; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; TIME SERIES ANALYSIS;

ANIMALS; BIOGENIC MONOAMINES; BRAIN; COCAINE; GTP-BINDING PROTEINS; MALE; MEMBRANE TRANSPORT MODULATORS; MEMBRANE TRANSPORT PROTEINS; PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, G-PROTEIN-COUPLED; TIME FACTORS;

EID: 18044365420     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.104.078451     Document Type: Article

References (40)

1. Appell M, Berfield JL, Wang LC, Dunn WJ, Chen N, and Reith ME (2004) Structure-activity relationships for substrate recognition by the human dopamine transporter. Biochem Pharmacol 67:293-302.
2. Araki T, Kato H, Shuto K, Fujimwara T, and Itoyama Y (1997) Effect of aging on dopaminergic receptors and uptake sites in the rat brain studied by receptor autoradiography. J Neurol Sci 148:131-137.
3. Beitner-Johnson D, Guitart X, and Nestler EJ (1992) Common intracellular actions of chronic morphine and cocaine in dopaminergic brain reward regions, in The Neurobiology of Drug and Alcohol Addiction (Kalivas PW and Samson HH eds) pp 70-87, New York Academy of Sciences, New York, NY.
4. Bennett BA, Wichems CH, Hollingsworth CK, Davies HML, Thornley C, Sexton T, and Childers SR (1995) Novel 2-substituted cocaine analogs: uptake and ligand binding studies at dopamine, serotonin and norepinephrine transport sites in the rat brain. J Pharmacol Exp Ther 272:1176-1186.
5. Birnbaumer L, Abramowitz J, and Brown AM (1990) Receptor-effector coupling by G proteins. Biochim Biophys Acta 1031:163-224.
6. 125I]RTI-55 to dopamine and serotonin transporters in rat brain. Synapse 12:27-36.
7. Breivogel CS, Childers SR, Deadwyler SA, Hampson RE, Vogt LJ, and Sim-Selley LJ (1999) Chronic Δ9-tetrahydrocannabinol produces a time-dependent loss of cannabinoid receptors and cannabinoid receptor-activated G-proteins in rat brain. J Neurochem 73:2447-2459.
8. Breivogel CS, Selley DE, and Childers SR (1997a) Acute and chronic effects of opioids on delta and mu receptor activation of G-proteins in NG108-15 and SK-N-SH cell membranes. J Neurochem 68:1462-1472.
9. Breivogel CS, Sim LJ, and Childers SR (1997b) Regional differences in cannabinoid receptor/G-protein coupling in rat brain. J Pharmacol Exp Ther 282:1632-1642.
10. Carroll FI, Abraham P, Lewin AH, Parham K, Boja JW, and Kuhar MJ (1992) Isopropyl and phenyl esters of 3β-(p-substituted phenyl)-tropane-2 β-carboxylic acids. Potent and selective compounds for the dopamine transporter. J Med Chem 35:2497-2500.
11. Daunais JB, Hart SL, Smith HR, Letchworth SR, Davies HML, Sexton T, Bennett B, Childers SR, and Porrino LJ (1998) Long-acting blockade of biogenic amine transporters in rat brain by administration of the potent novel tropane 2β-propranoyl-3β-(2-naphthyl)-tropane. J Pharmacol Exp Ther 285:1246-1254.
12. Davies HML, Saikali E, Huby NSJ, Gilliat VJ, Matasi J, Sexton T, and Childers SR (1994) Synthesis of 2-beta-acyl-aryl-8-azabicyclo[3.2.1]octanes and their binding affinities at dopamine and serotonin transport sites in rat striatum and frontal cortex. J Med Chem 37:1262-1268.
13. Davies HML, Saikali E, Sexton T, and Childers SR (1993) Novel 2-substituted cocaine analogs: binding properties at dopamine transport sites in rat striatum. Eur J Pharmacol 244:93-97.
14. Happe HK, Bylund DB, and Murrin LC (2000) Alpha(2)-adrenoceptor- stimulated GTPγS binding in rat brain: an autoradiographic study. Eur J Pharmacol 399:17-27.
15. Hemby SE, Co C, Reboussin D, Davies HM, Dworkin SI, and Smith JE (1995) Comparison of a novel tropane analog of cocaine, 2β-propanoyl-3β-(4- tolyl)tropane (PTT) with cocaine HCl in rats: nucleus accumbens extracellular dopamine concentration and motor activity. J Pharmacol Exp Ther 272:656-666.
16. 35S- GTPγS binding. Life Sci 69:1093-1102.
17. Lefkowitz RJ, Hausdorff WP, and Caron MG (1990) Role of phosphorylation in desensitization of the β-adrenoceptor. Trends Pharmacol 11:190-194.
18. Lile JA, Wang Z, Woolverton WL, France JE, Gregg TC, Davies HML, and Nader MA (2003) The reinforcing efficacy of psychostimulants in rhesus monkeys: the role of pharmacokinetics and pharmacodynamics. J Pharmacol Exp Ther 307:356-366.
19. 35S]thio)triphosphate binding. Mol Pharmacol 44:115-123.
20. Madras BK, Fahey MA, Miller GM, De La Garza R, Goulet M, Spealman RD, Meltzer PC, George SR, O'Dowd BF, Bonab AA, et al. (2003) Non-amine-based dopamine transporter (reuptake) inhibitors retain properties of amine-based progenitors. Eur J Pharmacol 479:41-51.
21. Mead AN, Rocha BA, Donovan DM, and Katz JL (2002) Intravenous cocaine induced-activity and behavioural sensitization in norepinephrine-, but not dopamine-transporter knockout mice. Eur J Neurosci 16:514-520.
22. Neve KA and Neve RL (1997) The Dopamine Receptors. Humana Press, Inc., Totowa, NJ.
23. 1A receptors. Eur J Pharmacol 307:107-111.
24. O'Connor KA, Gregg TC, Davies HML, and Childers SR (2004) Effects of long-term biogenic amine transporter blockade on receptor/G-protein coupling in rat brain. Neuropharmacology 48:62-71.
25. 3H]Spiperone binding sites in brain: autoradiographic localization of multiple receptors. Brain Res 213:277-289.
26. Post RM, Smith CC, Squillace KM, and Tallman JF (1979) Effect of chronic cocaine on behavior and cyclic AMP in cerebrospinal fluid of rhesus monkeys. Commun Psychopharmacol 3:143-152.
27. Post RM, Weiss SRB, and Pert A (1992) Sensitization and kindling effects of chronic cocaine administration, in Cocaine: Pharmacology, Physiology and Clinical Strategies (Lakoski JM, Galloway MP, and White FJ eds) pp 115-162, CRC Press LLC, Boca Raton, FL.
28. Reith ME, Benuck M, and Lajtha A (1987) Cocaine disposition in the brain after continuous or intermittent treatment and locomotor stimulation in mice. J Pharmacol Exp Ther 243:281-287.
29. 35S]GTPγS binding in rat striatal membranes. Biochem Pharmacol 57:155.
30. Ritz MC, Lamb RJ, Goldberg SR, and Kuhar MJ (1987) Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science (Wash DC) 237:1219-1223.
31. Roberts DC, Jungersmith KR, Phelan R, Gregg TM, and Davies HML (2003) Effect of HD-23, a potent long acting cocaine-analog, on cocaine self-administration in rats. Psychopharmacology 167:386-392.
32. 35S]GTPγS binding in rat brain. Synapse 47:26-32.
33. 35S]thio]-triphosphate binding. Proc Natl Acad Sci USA 92:7242-7246.
34. 35S] GTPγS autoradiography in rat brain. J Neurosci 16:2684-2692.
35. Sim-Selley LJ, Selley DE, Childers SR, and Martin TJ (2000a) Chronic heroin self-administration desensitizes mu opioid receptor-activated G-proteins in specific regions of rat brain. J Neurosci 20:4555-4562.
36. 1A receptor-activated G-proteins in rat brain following chronic buspirone. Eur J Pharmacol 389:147-153.
37. Sora I, Wichems C, Takahashi H, Li XF, Zeng Z, Revay R, Lesch KP, Murphy DL, and Uhl GR (2001) Cocaine reward models: conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice. Proc Natl Acad Sci USA 95:7699-7704.
38. 35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells. Mol Pharmacol 47:848-854.
39. 1 receptor-mediated signal transduction. Eur J Pharmacol 318:31-35.
40. Yoshiyuki W and Tsunehiko N (1997) Brain dopamine transporter in spontaneously hypertensive rats. J Nucl Med 38:470-474.